SCHEMBL31521430

SCHEMBL31521430

O=C(c1cccc(F)c1Cl)C1CC1(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 8/20 0.39
▸ CES2 O00748 2/20 0.38
▸ CES1 P23141 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ BCHE P06276 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ ALB P02768 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ GPR6 P46095 1/20 0.35
▸ MGLL Q99685 1/20 0.35
▸ FPR3 P25089 1/20 0.34
▸ FPR2 P25090 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31521268 0.78 CES2 (0.48) P2RX7CES2CES1ALDH1A1SMN1; SMN2
SCHEMBL31521419 0.75 P2RX7 (0.42) P2RX7CES2CES1ALDH1A1ALOX15
SCHEMBL31521338 0.73 P2RX7 (0.44) P2RX7CES2CES1ALDH1A1ALOX15
SCHEMBL7080990 0.73 CES2 (0.61) CES2CES1ALDH1A1ALOX15BCHE
SCHEMBL23079123 0.71 CES2 (0.48) P2RX7CES2CES1ALDH1A1ALOX15
SCHEMBL333947 0.71 TSHR (0.63) CES2CES1ALDH1A1ALOX15BCHE
SCHEMBL785155 0.71 ALDH1A1 (0.65) CES2CES1ALDH1A1ALOX15BCHE
SCHEMBL4442608 0.71 CES2 (0.48) CES2CES1ALDH1A1ALOX15BCHE
Hydrochloric Acid SCHEMBL15566176 0.71 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3GPR6MGLL
SCHEMBL4910880 0.70 PBRM1 (0.53) CES2CES1ALDH1A1ALOX15BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096957-A1 RAS-PI3K INHIBITORS AND USES THEREOF VIVIDION THERAPEUTICS, INC. (US) 2025-05-08 — — WO disclosed
Send feedback